Cogstate Ltd Announces Share Buy-Back Update
TipRanksApr 22 19:07 ET
Enrolment Completed in Actinogen's XanaCIDD Phase 2a Cognition & Depression Trial
Trial results anticipated in early Q3 this year SYDNEY, April 22, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces the full enrolment of 167 participants in the Company's XanaCIDD
PR NewswireApr 22 08:30 ET
Cogstate Ltd Continues Share Buy-Back Initiative
TipRanksApr 15 19:17 ET
Cogstate Ltd Continues Share Buy-Back Program
TipRanksApr 14 19:27 ET
Cogstate (ASX:CGS) Shareholders Have Earned a 42% CAGR Over the Last Five Years
Yahoo FinanceApr 14 18:33 ET
Cogstate Continues Aggressive Share Buy-Back
TipRanksApr 8 19:17 ET
Cogstate Ltd Continues Share Buy-Back Effort
TipRanksApr 7 19:47 ET
Cogstate Ltd Options Cease Amid Unmet Conditions
TipRanksApr 4 18:17 ET
Cogstate Ltd Seeks Quotation for New Securities
TipRanksApr 4 18:08 ET
Cogstate Continues Share Buy-Back Initiative
TipRanksApr 3 21:07 ET
Cogstate Amends License Agreement With Eisai for Alzheimer's Treatment
Cogstate (ASX:CGS) has amended its global license agreement with Eisai Co. Ltd. to re-acquire rights to a technology that would allow it to build an integrated system for Alzheimer's treatment, accord
MT NewswiresApr 1 17:52 ET
Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?
Yahoo FinanceMar 28 23:45 ET
Cogstate Limited (ASX:CGS) Insiders Have Significant Skin in the Game With 50% Ownership
Yahoo FinanceMar 12 17:49 ET
Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8%
Shares of Cogstate (ASX:CGS) declined nearly 8% in recent trade despite the company reporting Thursday that the net attributable profit after tax in the six-month period ended Dec. 31, 2023, grew to $
MT NewswiresFeb 21 20:18 ET
Bullish Cogstate Insiders Loaded Up On US$4.47m Of Stock
Yahoo FinanceDec 20, 2023 18:11 ET
Cogstate Ends Share Buyback Program
Cogstate (ASX:CGS) ended its share buyback program first disclosed last Feb. 23 as it enters a prohibited period as outlined in its share trading policy. Since the program began, the neurological asse
MT NewswiresDec 4, 2023 01:04 ET
Canaccord Genuity Remains a Buy on Cogstate Ltd (COGZF)
TipRanksOct 29, 2023 18:35 ET
Shareholders Will Probably Hold Off On Increasing Cogstate Limited's (ASX:CGS) CEO Compensation For The Time Being
Yahoo FinanceOct 17, 2023 23:53 ET
Parkinson's Disease Psychosis Market Is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Companies Working to Develop Therapies - Vanda, Kyowa Kirin, Sage, Athira, Aptinyx, CogState, AgeneBio
The dynamics of the Parkinson's disease psychosis market are anticipated to change in the coming years owing to the improvement in diagnosis methodologies, rising awareness of the disease, incrementa
PR NewswireOct 2, 2023 17:01 ET
Cogstate Joins Forces to Establish Dementia Insurance in Japan
Cogstate, (ASX:CGS) together with partner pharmaceutical firm Eisai (TYO:4523) established a dementia care support insurance in Japan co-developed with insurer Tokio Marine & Nichido Fire Insurance. T
MT NewswiresSep 28, 2023 04:37 ET
No Data
No Data